AC
PRME icon

AXQ Capital’s Prime Medicine PRME Stock Holding History

AXQ Capital’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$128K Buy
36,742
+3,337
+10% +$12.7K 0.02% 838
2025
Q4 		$116K Sell
33,405
-11,413
-25% -$50.8K 0.03% 637
2025
Q3 		$248K Buy
44,818
+7,231
+19% +$29.4K 0.1% 375
2025
Q2 		$92.8K Buy
+37,587
New +$57.9K 0.03% 523
2025
Q1 		– Sell
-15,363
Closed -$44.9K – 649
2024
Q4 		$44.9K Buy
+15,363
New +$53.9K 0.02% 403

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AXQ Capital's PRME Position: Q1 2026 in Review

AXQ Capital increased its Prime Medicine (PRME) stake by 10% in Q1 2026, buying an estimated $12.7K and bringing the position to 36,742 shares worth $128K. The position accounts for 0.02% of the portfolio, ranked #838.

AXQ Capital first reported a position in PRME in Q4 2024 and has held it in 5 quarters since. The position peaked at $248K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • AXQ Capital held 36,742 shares of Prime Medicine worth $128K as of Q1 2026.
  • AXQ Capital bought 3,337 Prime Medicine shares in Q1 2026, an estimated $12.7K.
  • Prime Medicine made up 0.02% of AXQ Capital's portfolio in Q1 2026, its #838 holding.
  • AXQ Capital first reported a position in Prime Medicine in Q4 2024 and has held it in 5 quarters since.
  • AXQ Capital's Prime Medicine position peaked at $248K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.